Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 20;12(8):e0006734.
doi: 10.1371/journal.pntd.0006734. eCollection 2018 Aug.

Laboratory selection of Aedes aegypti field populations with the organophosphate malathion: Negative impacts on resistance to deltamethrin and to the organophosphate temephos

Affiliations

Laboratory selection of Aedes aegypti field populations with the organophosphate malathion: Negative impacts on resistance to deltamethrin and to the organophosphate temephos

Priscila Fernandes Viana-Medeiros et al. PLoS Negl Trop Dis. .

Abstract

Background: Resistance to pyrethroids and to the organophosphate temephos is widespread in Brazilian populations of the dengue vector, Aedes aegypti. Thereof, since 2009 Insect Growth Regulators are employed as larvicides, and malathion is used against adults.

Methodology/principal findings: We performed laboratory selection with malathion of two A. aegypti field populations initially susceptible to this organophosphate but resistant to temephos and deltamethrin. A fixed malathion dose inducing at least 80% mortality in the first generation, was used throughout the selection process, interrupted after five generations, when the threshold of 20% mortality was reached. For each population, three experimental and two control groups, not exposed to insecticides, were kept independently. For both populations, quantitative bioassays revealed, in the selected groups, acquisition of resistance to malathion and negative impact of malathion selection on deltamethrin and temephos resistance levels. In the control groups resistance to all evaluated insecticides decreased except, unexpectedly, to deltamethrin. Analysis of the main resistance mechanisms employed routine methodologies: biochemical and molecular assays for, respectively, metabolic resistance and quantification of the NaV pyrethroid target main kdr mutations at positions 1016 and 1534. No diagnostic alteration could be specifically correlated with malathion selection, neither with the unusual deltamethrin increase in resistance levels observed in the control groups.

Conclusions/significance: Our results confirm the multifactorial character of insecticide resistance and point to the need of high throughput methodologies and to the study of additional field vector populations in order to unravel resistance mechanisms.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Survival rate of two Aedes aegypti populations subjected to selection with a fixed dose of malathion.
Exposure to the insecticide was continuous, between L3 and pupal phases. The x-axis indicates the generations of laboratory rearing.

Similar articles

Cited by

References

    1. Ferreira-de-Brito A, Ribeiro IP, Miranda RM, Fernandes RS, Campos SS, Silva KA et al. First detection of natural infection of Aedes aegypti with Zika virus in Brazil and throughout South America. Mem Inst Oswaldo Cruz. 2016; 111(10): 655–658. 10.1590/0074-02760160332 - DOI - PMC - PubMed
    1. Sanofi Pasteur (2016). Comunicado de imprensa: a vacina contra dengue da Sanofi Pasteur é aprovada no Brasil. Available in: http://www.sanofi.com.br/l/br/medias/524EE272-23C5-4319-B849-70B1D9ECBFD... (Accessed on 25 January 2016).
    1. Schwartz LM, Halloran ME, Durbin AP, Longini IM Jr. The dengue vaccine pipeline: implications for the future of dengue control. Vaccine. 2015; 33: 3293–3298. 10.1016/j.vaccine.2015.05.010 - DOI - PMC - PubMed
    1. Khetarpal N, Khanna I. Dengue fever. causes, complications, and vaccine strategies. J Immunol Res. 2016; Article ID 6803098, 14 pages. - PMC - PubMed
    1. NIAID/NIH (2017). Zika virus vaccines. Available in: https://www.niaid.nih.gov/diseases-conditions/zika-vaccines (Acessed on 19 July 2017).

Publication types

LinkOut - more resources